This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Sep 28;389(13):1248-1249.

doi: 10.1056/NEJMc2309584.

Antibody NI006 for Cardiac Transthyretin Amyloid Depletion

Affiliations

PMID: 37754295
DOI: 10.1056/NEJMc2309584

Comment

Antibody NI006 for Cardiac Transthyretin Amyloid Depletion

Max Berrill. N Engl J Med. 2023.

. 2023 Sep 28;389(13):1248-1249.

doi: 10.1056/NEJMc2309584.

Author

Affiliation

¹ St. Bartholomew's Hospital, London, United Kingdom max.berrill@nhs.net.

PMID: 37754295
DOI: 10.1056/NEJMc2309584

No abstract available

PubMed Disclaimer

Comment on

Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid.
Garcia-Pavia P, Aus dem Siepen F, Donal E, Lairez O, van der Meer P, Kristen AV, Mercuri MF, Michalon A, Frost RJA, Grimm J, Nitsch RM, Hock C, Kahr PC, Damy T. Garcia-Pavia P, et al. N Engl J Med. 2023 Jul 20;389(3):239-250. doi: 10.1056/NEJMoa2303765. Epub 2023 May 20. N Engl J Med. 2023. PMID: 37212440 Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program